Cillian King

Founder at

Koala Life Sciences BV

Finance

Health Technology

Consumer Services

Profile

Dr. Cillian King is a Partner at EQT Life Sciences Group BV and a Founder at Koala Life Sciences BV.
He is on the Board of Directors at Sairopa B V, Muna Therapeutics ApS and QurAlis Corp.
Dr. King was previously employed as a Chairman-Supervisory Board by Allero Therapeutics BV and an Investment Manager by Swanbridge Capital Management BV.
He received his doctorate degree from Vrije Universiteit Amsterdam.

Cillian King active positions

Companies	Position	Start
Muna Therapeutics ApS Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases	Director/Board Member	-
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Private Equity Investor	01/01/2021
Koala Life Sciences BV	Founder	01/01/2017
QurAlis Corp. QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications	Director/Board Member	-
Sairopa B V Sairopa B V MiscellaneousMiscellaneous Develops medicines and functions as an investment holding company	Director/Board Member	01/01/2021

All active positions of Cillian King

Former positions of Cillian King

Companies	Position	End
Swanbridge Capital Management BV Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital invests in Life Sciences companies located in the Rotterdam Science Tower we are in the very heart of the Life Sciences startup eco-system. The firm invests in early stage companies.	Private Equity Investor	01/01/2021
Allero Therapeutics BV Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases	Chairman	01/01/2021

See the detail of Cillian King's experience

Training of Cillian King

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cillian King's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
LSP Management Group BV LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million.	Finance
Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Swanbridge Capital Management BV Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital invests in Life Sciences companies located in the Rotterdam Science Tower we are in the very heart of the Life Sciences startup eco-system. The firm invests in early stage companies.	Finance
QurAlis Corp. QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications	Health Technology
Allero Therapeutics BV Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases	Commercial Services
Muna Therapeutics ApS Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases	Health Technology
Koala Life Sciences BV
Sairopa B V Sairopa B V MiscellaneousMiscellaneous Develops medicines and functions as an investment holding company	Miscellaneous